122 related articles for article (PubMed ID: 11937251)
1. Radiosurgery for brain metastases: the Tuebingen experience.
Becker G; Jeremic B; Engel C; Buchgeister M; Paulsen F; Duffner F; Meisner C; Bamberg M
Radiother Oncol; 2002 Feb; 62(2):233-7. PubMed ID: 11937251
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
[TBL] [Abstract][Full Text] [Related]
5. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.
Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2003 Feb; 98(2):342-9. PubMed ID: 12593621
[TBL] [Abstract][Full Text] [Related]
6. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control.
Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2002 Dec; 97(6):1276-81. PubMed ID: 12507123
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery for 318 brain metastases in a single Australian centre: the impact of histology and other factors.
Sia J; Paul E; Dally M; Ruben J
J Clin Neurosci; 2015 Feb; 22(2):303-7. PubMed ID: 25304434
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
9. Gamma knife radiosurgery for malignant melanoma brain metastases.
Seung SK; Sneed PK; McDermott MW; Shu HK; Leong SP; Chang S; Petti PL; Smith V; Verhey LJ; Wara WM; Phillips TL; Larson DA
Cancer J Sci Am; 1998; 4(2):103-9. PubMed ID: 9532412
[TBL] [Abstract][Full Text] [Related]
10. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection.
Kurtz G; Zadeh G; Gingras-Hill G; Millar BA; Laperriere NJ; Bernstein M; Jiang H; Ménard C; Chung C
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):137-42. PubMed ID: 24331660
[TBL] [Abstract][Full Text] [Related]
11. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
[TBL] [Abstract][Full Text] [Related]
12. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma.
Powell JW; Chung CT; Shah HR; Canute GW; Hodge CJ; Bassano DA; Liu L; Mitchell L; Hahn SS
J Neurosurg; 2008 Dec; 109 Suppl():122-8. PubMed ID: 19123898
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery.
Gao HX; Huang SG; Du JF; Zhang XC; Jiang N; Kang WX; Mao J; Zhao Q
Int J Biol Sci; 2018; 14(14):2065-2072. PubMed ID: 30585269
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
15. Radiosurgery for brain metastasis: impact of CTV on local control.
Noël G; Simon JM; Valery CA; Cornu P; Boisserie G; Hasboun D; Ledu D; Tep B; Delattre JY; Marsault C; Baillet F; Mazeron JJ
Radiother Oncol; 2003 Jul; 68(1):15-21. PubMed ID: 12885447
[TBL] [Abstract][Full Text] [Related]
16. Radiosurgery for brain metastases: is whole brain radiotherapy necessary?
Sneed PK; Lamborn KR; Forstner JM; McDermott MW; Chang S; Park E; Gutin PH; Phillips TL; Wara WM; Larson DA
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):549-58. PubMed ID: 10078636
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery.
Fernandez-Vicioso E; Suh JH; Kupelian PA; Sohn JW; Barnett GH
Radiat Oncol Investig; 1997; 5(1):31-7. PubMed ID: 9303054
[TBL] [Abstract][Full Text] [Related]
18. The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery.
Routman DM; Bian SX; Diao K; Liu JL; Yu C; Ye J; Zada G; Chang EL
Cancer Med; 2018 Mar; 7(3):757-764. PubMed ID: 29441722
[TBL] [Abstract][Full Text] [Related]
19. Linear accelerator radiosurgery in the treatment of brain metastases.
Ulm AJ; Friedman WA; Bova FJ; Bradshaw P; Amdur RJ; Mendenhall WM
Neurosurgery; 2004 Nov; 55(5):1076-85. PubMed ID: 15509314
[TBL] [Abstract][Full Text] [Related]
20. Brain metastasis from renal cell carcinoma.
Bennani O; Derrey S; Langlois O; Castel H; Laquerriere A; Freger P; Proust F
Neurochirurgie; 2014; 60(1-2):12-6. PubMed ID: 24636403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]